Chatterjee; Subroto

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chatterjee; Subroto.The latest application filed is for "biopolymer-encapsulated glycosyl transferase inhibitor compositions and methods for treating diabetes and cardiac indications".

Company Profile

0.14.20

Chatterjee; Subroto - Columbia MD
Chatterjee; Subroto - Baltimore MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Biopolymer-encapsulated Glycosyl Transferase Inhibitor Compositions And Methods For Treating Diabetes And Cardiac Indications App 20210386678 - Chatterjee; Subroto	2021-12-16
Biopolymer-encapsulated Glycosyl Transferase Inhibitor Compositions And Methods For Treating Diabetes And Cardiac Indications App 20170119683 - Chatterjee; Subroto	2017-05-04
Anti-cholesterolemic Compounds And Methods Of Use App 20170014362 - Chatterjee; Subroto	2017-01-19
Anti-cholesterolemic compounds and methods of use Grant 9,376,369 - Chatterjee June 28, 2	2016-06-28
Use of the lactosylceramide synthase isoform B1,4GalT-V as a biomarker for cancer Grant 9,134,315 - Chatterjee September 15, 2	2015-09-15
Compositions And Methods For Treating Cardiac Hypertrophy App 20150118221 - Chatterjee; Subroto	2015-04-30
Novel Apoc-i Isoforms And Their Use As Biomarkers And Risk Factors Of Atherosclerotic Disease App 20140193846 - Macfarlane; Ronald D. ; et al.	2014-07-10
Methods Of Diagnosing Atherosclerosis By Measuring Apoci App 20140141017 - Chatterjee; Subroto ; et al.	2014-05-22
Anti-cholesterolemic Compounds And Methods Of Use App 20140031304 - Chatterjee; Subroto ; et al.	2014-01-30
Methods of diagnosing atherosclerosis by measuring ApoCI Grant 8,614,064 - Chatterjee , et al. December 24, 2	2013-12-24
Anti-cholesterolemic compounds and methods of use Grant 8,492,351 - Chatterjee , et al. July 23, 2	2013-07-23
Use of the Lactosylceramide Synthase Isoform B1,4GALT-V as a Biomarker for Cancer App 20130041015 - Chatterjee; Subroto	2013-02-14
Anti-cholesterolemic Compounds And Methods Of Use App 20100063153 - Chatterjee; Subroto ; et al.	2010-03-11
PELCAM-1-related molecules compositions kit of parts and associated methods of use App 20090215171 - Chatterjee; Subroto ; et al.	2009-08-27
Pecam-1 Genotype App 20090208934 - Chatterjee; Subroto ; et al.	2009-08-20
Methods for treatment of angiogenesis App 20090202439 - Chatterjee; Subroto	2009-08-13
Apolipoprotein c-1 induced apoptosis App 20070178438 - Chatterjee; Subroto ; et al.	2007-08-02
Neutral sphingomyelinase antisense ribozyme and uses thereof Grant 7,230,094 - Chatterjee June 12, 2	2007-06-12
PECAM-1-related molecules compositions kit of parts and associated methods of use App 20060127921 - Chatterjee; Subroto ; et al.	2006-06-15
Compositions and methods for modulating serum cholesterol App 20050079998 - Chatterjee, Subroto	2005-04-14
Compositions and methods for modulating serum cholesterol Grant 6,713,057 - Chatterjee March 30, 2	2004-03-30
Methods for treating conditions modulated by lactosylceramide Grant 6,511,979 - Chatterjee January 28, 2	2003-01-28
Recombinant N-smases And Nucleic Acids Encoding Same App 20020160484 - CHATTERJEE, SUBROTO	2002-10-31
Methods for treatment of conditions associated with lactosylceramide Grant 6,228,889 - Chatterjee May 8, 2	2001-05-08
Methods for treatment of conditions associated with lactosylceramide Grant 5,972,928 - Chatterjee October 26, 1	1999-10-26
Recombinant N-SMases and nucleic acids encoding same Grant 5,919,687 - Chatterjee July 6, 1	1999-07-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.